Brevitest Technologies
Houston
About Brevitest Technologies
Brevitest Technologies is a developer of a point-of-care medical device to assist enzyme immunoassays for early-stage detection of diseases. Its portable and automated analyzer performs enzyme-linked immunosorbent assays in less than ten minutes using customizable disposable cartridges suitable for detecting and quantifying peptides, proteins, antibodies, and hormones in biological samples that enable medical researchers to replace painful, time-consuming laboratory-based diagnostics and detect abnormalities in enzymes in a cost-effective manner.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $2.7M
- Last round: Series Unknown (Dec 2020)
- Website: brevitest.com
- Phone: +7139665844
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/brevitest-technologies-584 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.